In Taiwan, clinical trials for drug registration follow international standards. Phase I assesses safety and dosage in small groups. Phase II evaluates efficacy and side effects in larger groups. Phase III involves large-scale testing to confirm effectiveness and monitor adverse reactions. Data from all phases must be submitted to the TFDA.
